Pfizer To Study Anti-COVID Pill In Kids

Pfizer To Study Anti-COVID Pill In Kids

Assessment

Interactive Video

Health Sciences, Biology

University

Hard

Created by

Quizizz Content

FREE Resource

Pfizer's anti-COVID pill, Paxil Ovid, is approved for high-risk patients aged 12 and older. The company is now studying its efficacy in children aged 6 to 18. Paxil Ovid can be taken after COVID symptoms appear and reduces the risk of death and hospitalization. Pfizer's CEO is optimistic about FDA approval for their vaccine for children under 5, with data to be reviewed soon.

Read more

1 questions

Show all answers

1.

OPEN ENDED QUESTION

3 mins • 1 pt

What new insight or understanding did you gain from this video?

Evaluate responses using AI:

OFF